The rollercoaster ride to anti-cancer antibodies

Nat Biotechnol. 2003 May;21(5):510-1. doi: 10.1038/nbt0503-510.
No abstract available

Publication types

  • Congress
  • News

MeSH terms

  • Animals
  • Antibodies / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antibodies, Neoplasm / immunology
  • Antineoplastic Agents / immunology*
  • Antineoplastic Agents / therapeutic use*
  • Drug Design
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / immunology*
  • Protein Engineering / methods*
  • Rituximab
  • Trastuzumab

Substances

  • Antibodies
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Rituximab
  • Trastuzumab